From: Design of study without drugs—a Surinamese school-based drug-prevention program for adolescents
Country | Lifetime prevalence | Past-year prevalence | Past-month prevalence |
---|---|---|---|
Antigua and Barbuda | 17.31 | 4.47 | 1.79 |
Barbados | 21.46 | 8.25 | 3.66 |
Dominica | 30.69 | 13.22 | 7.76 |
Grenada | 34.53 | 10.75 | 5.45 |
Guyana | 17.66 | 6.10 | 4.13 |
Haiti | 9.20 | 3.25 | 1.49 |
Jamaica | 24.61 | 8.37 | 4.44 |
St Kitts and Nevis | 11.82 | 4.00 | 1.98 |
St Lucia | 27.84 | 11.31 | 5.97 |
St Vincent and the Grenadines | 21.01 | 5.43 | 2.66 |
Suriname | 33.06 | 14.15 | 7.15 |
Trinidad and Tobago | 28.86 | 11.36 | 5.61 |
Average | 25.60 | 9.45 | 4.94 |